InMed Pharmaceuticals Inc. Gains 36.33%
Wed, Nov 16, 2022 at 07:29 PM
InMed Pharmaceuticals Inc. (INM:NASDAQ) soared at $3.79, a gain of 36.3%. On Wed, Nov 16, 2022, INM:NASDAQ touched a New 2-Week High of $3.79. The stock appeared on our News Catalysts scanner on Wed, Nov 16, 2022 at 02:31 PM in the 'BIOTECH' category. From Wed, Nov 02, 2022, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Wed, Nov 16, 2022 at $4.75 with a volume of 28M+.
About InMed Pharmaceuticals Inc. (INM:NASDAQ)
InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company.
Top 10 Gainers:
- Fast Radius Inc. (FSRD:NASDAQ), 106.29%
- InMed Pharmaceuticals Inc. (INM:NASDAQ), 36.33%
- Foresight Autonomous Holdings Ltd. (FRSX:NASDAQ), 33.04%
- XL Group Ltd (XL:NYSE), 30.91%
- Ensysce Biosciences Inc. (ENSC:NASDAQ), 29.17%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 28.32%
- Creatd Inc. (CRTD:NASDAQ), 22.12%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 21.99%
- BYND Cannasoft Enterprises Inc. (BCAN:NASDAQ), 19.67%
- Oncorus Inc. (ONCR:NASDAQ), 18.61%